20Jun/13

Character counts when it comes to organ, blood donations – MyFox Austin


domain-B

Character counts when it comes to organ, blood donations
MyFox Austin
WEDNESDAY, June 19 (HealthDay News) — Some people say they would refuse an organ or blood donation that came from a murderer or thief, a new study shows. Many people believe behaviors and personality traits are tied to something deep within a 
Why some fear blood transfusionTimes of India
For some, it matters who’s donating an organ, blooddomain-B
Study: Organ Recipients Picky About Donor BackgroundCBS Local

all 4 news articles »

20Jun/13

The Indian High Commission in Dhaka will organise a voluntary blood donation … – Bangladesh News 24 hours


Daily News & Analysis

The Indian High Commission in Dhaka will organise a voluntary blood donation
Bangladesh News 24 hours
The Indian High Commission in Dhaka will organise a voluntary blood donation camp on Friday at its Indira Gandhi Cultural Centre in the capital’s Gulshan area. Bangladesh Red Crescent Society will help it in its “efforts within Bangladesh to augment 
Donate blood in Mapleton June 26 to help prevent a blood shortageBlair Enterprise Publishing

all 4 news articles »

20Jun/13

Two Studies Evaluating the Combination of REVLIMID ® and rituximab in Non … – EON: Enhanced Online News (press release)

Two Studies Evaluating the Combination of REVLIMID ® and rituximab in Non
EON: Enhanced Online News (press release)
“The increasing volume of clinical evidence evaluating combinations utilizing REVLIMID plus rituximab provide us powerful insight into the potential of antibody-dependent cellular cytotoxicity in lymphomas, and the potential of these novel combinations

and more »

20Jun/13

Celgene Announces Results of Two Studies Evaluating Combo of Revlimid … – Benzinga

Celgene Announces Results of Two Studies Evaluating Combo of Revlimid
Benzinga
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that results from two studies evaluating the combination of REVLIMID^® (lenalidomide) and rituximab in various non-Hodgkin’s lymphomas 
Two Studies Evaluating the Combination of REVLIMID ® and rituximab in Non EON: Enhanced Online News (press release)

all 3 news articles »

20Jun/13

Celgene (CELG) Presents Data on Two REVLIMID + Rituximab Studies – StreetInsider.com (subscription)

Celgene (CELG) Presents Data on Two REVLIMID + Rituximab Studies
StreetInsider.com (subscription)
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that results from two studies evaluating the combination of REVLIMID (lenalidomide) and rituximab in various non-Hodgkin’s lymphomas were 

20Jun/13

Two Studies Evaluating the Combination of REVLIMID(R) and rituximab in Non … – MarketWatch (press release)

Two Studies Evaluating the Combination of REVLIMID(R) and rituximab in Non
MarketWatch (press release)
Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) , today announced that results from two studies evaluating the combination of REVLIMID(R) (lenalidomide) and rituximab in various non-Hodgkin’s lymphomas 
Two Studies Evaluating the Combination of REVLIMID ® and rituximab in Non EON: Enhanced Online News (press release)

all 3 news articles »